Marvelon

Desogestrel, the active ingredient in Marvelon, is a combined oral contraceptive presented as 150 µg desogestrel / 30 µg ethinylestradiol oral tablet for oral use. It prevents pregnancy and provides hormonal contraception for women of reproductive age, while the ethinylestradiol component helps regulate the menstrual cycle.

GNH USA supplies Marvelon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Marvelon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent unintended pregnancy.

- Pregnancy prevention: provides reliable hormonal contraception for women of reproductive age. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces dysmenorrhea. - Management of estrogen‑dependent conditions: may be prescribed to treat certain menstrual disorders such as endometriosis‑related pain.

Common and serious adverse reactions have been reported with combined oral contraceptives such as Marvelon.

Common Side Effects: - Nausea - Breast tenderness - Headache - Weight gain - Mood changes - Spotting between periods

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism) - Arterial thrombosis (stroke, myocardial infarction) - Severe hypertension - Liver dysfunction or cholestasis - Allergic reactions (anaphylaxis, severe rash)

Before prescribing Marvelon, clinicians should consider several safety and handling precautions.

- Contraindicated in pregnancy: the product must not be used by women who are or may become pregnant. - Smoking over age 35: increases risk of cardiovascular events and is a contraindication. - History of thromboembolism: avoid use in patients with prior deep‑vein thrombosis or pulmonary embolism. - Liver disease: impaired hepatic function may alter hormone metabolism. - Hypertension: uncontrolled high blood pressure requires caution or avoidance. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Marvelon may interact with several medicines that alter hormone levels or increase the risk of adverse events.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) markedly reduce contraceptive efficacy. - Rifampicin and other strong CYP3A4 inducers can lead to contraceptive failure. - St John’s wort: herbal inducer that may lower hormone concentrations. - Certain antiretrovirals (e.g., ritonavir) may increase hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: oral contraceptives may diminish blood‑pressure‑lowering effect. - SSRIs and other antidepressants: may increase bleeding tendency. - Diuretics: can affect electrolyte balance when combined with estrogen. - Antifungals (e.g., fluconazole) may raise hormone levels modestly.